Stay updated with breaking news from Exhibition Level. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Supira's technology features a novel low profile, high continuous flow design that aims to provide full hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic shock (CS) patients with a single device
/PRNewswire/ -- Supira Medical, Inc., a Shifamed portfolio company, announced today that the company's percutaneous ventricular assist device (pVAD) will be...
Novel platform for structural heart interventions now in human use, with ability to improve patient recovery and reduce anesthesia and hospital stays
Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Oct. 24, 25 and 26
Novel platform for structural heart interventions now in human use, with ability to improve patient recovery and reduce anesthesia and hospital stays